Version June 2024
| Initial dose for psoriasis | ||||
| Plaque thickness | Induration score | Fitzpatrick skin type I-III (dose in mJ/cm2) | Fitzpatrick skin type IV-VI (dose in mJ/cm2) | |
| None | 0 | |||
| Mild | 1 | 300 | 400 | |
| Moderate | 2 | 500 | 600 | |
| Severe | 3 | 700 | 900 | |
| Dose for subsequent treatments | ||||
| No effect | Minimal effect | Good effect | Considerable improvement | Moderate/severe erythema |
| No erythema at 12 to 24 hours and no plaque improvement | Slight erythema at 12 to 24 hours but no significant improvement | Mild to moderate erythema response 12 to 24 hours | Significant improvement with plaque thinning or reduced scaliness or pigmentation occurred | With or without blistering |
| Increase dose by 25% | Increase dose by 15% | Maintain dose | Maintain dose or reduce dose by 15% | Reduce dose by 25% (treat around blistered area, do not treat blistered area until it heals or crust disappears) |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟
